• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性髓系细胞触发受体-1(sTREM-1)和可溶性ST2(sST2)联合诊断对脓毒症检测及预后预测的意义

Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction.

作者信息

Wei Yongjun, Xiao Ping, Wu Benjuan, Chen Fuxi, Shi Xiaofeng

机构信息

Department of Emergency, Tianjin First Central Hospital, Tianjin, 300192, China.

Department of Emergency, Tianjin Beichen Hospital, Tianjin, 300400, China.

出版信息

Open Life Sci. 2023 Aug 17;18(1):20220639. doi: 10.1515/biol-2022-0639. eCollection 2023.

DOI:10.1515/biol-2022-0639
PMID:37601077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436778/
Abstract

The diagnosis of sepsis still lacks a practical and reliable gold standard. The purpose of this study was to confirm the effect of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) combined with soluble suppression of tumorigenicity 2 (sST2) in the diagnosis of sepsis through the correlation between sTREM-1, sST2, and sequential organ failure assessment (SOFA) scores. Baseline data of 91 patients with sepsis in the intensive care unit were collected, sTREM-1 and sST2 were detected, and the correlation between markers and SOFA score was analyzed. Besides, the prognostic value of baseline and postadmission indicators for sepsis was analyzed with death as the outcome. The results showed that the expressions of sST2 and sTREM-1 in death group and survival group were higher than those in the survival group ( < 0.05). Correlation analysis showed that sST2, sTREM-1, and the joint diagnosis model had a high correlation with SOFA score ( < 0.05), but poor correlation with Acute Physiology and Chronic Health Evaluation Ⅱ score ( > 0.05). Among them, joint diagnosis model has the highest correlation. Receiver operating characteristic curve analysis showed that combined diagnosis had higher area under curve values. sTREM-1/sST2 can be better used in the diagnosis of sepsis than the single biomarker detection, and the combination of the above two biomarkers has potential application value in the detection and prognosis prediction of sepsis.

摘要

脓毒症的诊断仍缺乏实用且可靠的金标准。本研究的目的是通过髓系细胞触发受体-1(sTREM-1)、可溶性肿瘤抑制因子2(sST2)与序贯器官衰竭评估(SOFA)评分之间的相关性,来证实sTREM-1联合sST2在脓毒症诊断中的作用。收集了重症监护病房91例脓毒症患者的基线数据,检测sTREM-1和sST2,并分析标志物与SOFA评分之间的相关性。此外,以死亡为结局,分析脓毒症基线和入院后指标的预后价值。结果显示,死亡组和存活组中sST2和sTREM-1的表达均高于存活组(<0.05)。相关性分析表明,sST2、sTREM-1及联合诊断模型与SOFA评分具有高度相关性(<0.05),但与急性生理与慢性健康状况评分Ⅱ相关性较差(>0.05)。其中,联合诊断模型的相关性最高。受试者工作特征曲线分析表明,联合诊断的曲线下面积值更高。与单一生物标志物检测相比,sTREM-1/sST2能更好地用于脓毒症的诊断,上述两种生物标志物的联合在脓毒症的检测和预后预测中具有潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/102e5fb00f96/j_biol-2022-0639-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/29c113138bd2/j_biol-2022-0639-ga001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/c0aed30a2f0e/j_biol-2022-0639-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/59003bb65398/j_biol-2022-0639-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/102e5fb00f96/j_biol-2022-0639-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/29c113138bd2/j_biol-2022-0639-ga001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/c0aed30a2f0e/j_biol-2022-0639-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/59003bb65398/j_biol-2022-0639-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7903/10436778/102e5fb00f96/j_biol-2022-0639-fig003.jpg

相似文献

1
Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction.可溶性髓系细胞触发受体-1(sTREM-1)和可溶性ST2(sST2)联合诊断对脓毒症检测及预后预测的意义
Open Life Sci. 2023 Aug 17;18(1):20220639. doi: 10.1515/biol-2022-0639. eCollection 2023.
2
Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study.血清髓系细胞表面表达的可溶性触发受体-1和降钙素原可反映脓毒症严重程度并预测预后:一项前瞻性队列研究
Mediators Inflamm. 2014;2014:641039. doi: 10.1155/2014/641039. Epub 2014 Feb 4.
3
Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.脓毒症致重症监护病房患者髓系细胞触发受体-1升高的意义
BMC Infect Dis. 2016 Oct 12;16(1):559. doi: 10.1186/s12879-016-1893-4.
4
[Clinical study on plasma soluble triggering receptor expressed on myeloid cells-1 in patients with sepsis].[脓毒症患者血浆髓系细胞触发受体-1的临床研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 May;23(5):283-5.
5
[Value of sTREM-1 in serum and bronchoalveolar lavage fluid, APACHE II score, and SOFA score in evaluating the conditions and prognosis of children with severe pneumonia].血清和支气管肺泡灌洗液体中可溶性髓系细胞触发受体-1、急性生理学与慢性健康状况评分系统II评分及序贯器官衰竭评估评分在评估重症肺炎患儿病情及预后中的价值
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Jun;22(6):626-631. doi: 10.7499/j.issn.1008-8830.1912134.
6
[Expression of soluble triggering receptor expressed on myeloid cells-1 in septic patients and its relation with prognosis].[脓毒症患者髓系细胞触发受体-1的可溶性表达及其与预后的关系]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 May;23(5):305-8.
7
Soluble Triggering Receptor Expressed on Myeloid Cells-1 as a Novel Marker for Abdominal Sepsis.髓系细胞表面表达的可溶性触发受体-1作为腹部脓毒症的新型标志物
Surg Infect (Larchmt). 2017 Jul;18(5):577-581. doi: 10.1089/sur.2016.174. Epub 2017 Mar 7.
8
Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis.可溶性髓系细胞触发受体-1(sTREM-1)和促炎细胞因子(sCD14-ST)在脓毒症诊断和预后标志物中的应用。
Clin Lab. 2020 Apr 1;66(4). doi: 10.7754/Clin.Lab.2019.190508.
9
The Prognostic Value of Serum Soluble TREM-1 on Outcome in Adult Patients with Sepsis.血清可溶性髓系细胞触发受体-1对成年脓毒症患者预后的评估价值
Diagnostics (Basel). 2021 Oct 25;11(11):1979. doi: 10.3390/diagnostics11111979.
10
Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study.血清可溶性髓系细胞触发受体-1(sTREM-1)的动态变化反映脓毒症的严重程度,并可预测预后:一项前瞻性研究。
BMC Infect Dis. 2011 Mar 1;11:53. doi: 10.1186/1471-2334-11-53.

引用本文的文献

1
Value of SOFA score, APACHE II score, and WBC count for mortality risk assessment in septic patients: A retrospective study.序贯器官衰竭评估(SOFA)评分、急性生理与慢性健康状况评分系统(APACHE)II评分及白细胞计数在脓毒症患者死亡风险评估中的价值:一项回顾性研究
Medicine (Baltimore). 2025 May 16;104(20):e42464. doi: 10.1097/MD.0000000000042464.
2
Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis.可溶性肿瘤抑制因子2(sST2)作为急性心力衰竭和脓毒症的诊断及预后标志物:一项对比分析
Diagnostics (Basel). 2025 Apr 16;15(8):1010. doi: 10.3390/diagnostics15081010.
3

本文引用的文献

1
Immunopathophysiology of human sepsis.人类脓毒症的免疫病理生理学。
EBioMedicine. 2022 Dec;86:104363. doi: 10.1016/j.ebiom.2022.104363. Epub 2022 Dec 2.
2
Risk factors for acute respiratory distress syndrome in sepsis patients: a retrospective study from a tertiary hospital in China.脓毒症患者急性呼吸窘迫综合征的危险因素:中国一家三甲医院的回顾性研究。
BMC Pulm Med. 2022 Jun 21;22(1):238. doi: 10.1186/s12890-022-02015-w.
3
Association of Soluble Suppression of Tumorigenicity 2 with New-Onset Atrial Fibrillation in Acute Myocardial Infarction.
The diagnostic and prognostic value of soluble ST2 in Sepsis.
可溶性ST2在脓毒症中的诊断和预后价值。
Front Med (Lausanne). 2024 Nov 21;11:1487443. doi: 10.3389/fmed.2024.1487443. eCollection 2024.
4
Correlation of serum H-FABP, sTREM-1, and HMGB1 levels with severity and prognosis of sepsis.血清H-FABP、sTREM-1和HMGB1水平与脓毒症严重程度及预后的相关性
Am J Transl Res. 2024 Oct 15;16(10):5846-5855. doi: 10.62347/KELZ4296. eCollection 2024.
可溶性肿瘤抑制因子2与急性心肌梗死新发心房颤动的关联
Cardiology. 2022;147(4):381-388. doi: 10.1159/000524765. Epub 2022 May 17.
4
The immunology of sepsis.脓毒症的免疫学。
Immunity. 2021 Nov 9;54(11):2450-2464. doi: 10.1016/j.immuni.2021.10.012.
5
A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).新型心脏生物标志物在急性或慢性心血管疾病中的研究进展:可溶性 ST2(sST2)、脂蛋白相关磷脂酶 A2(Lp-PLA2)、髓过氧化物酶(MPO)和降钙素原(PCT)的作用。
Dis Markers. 2021 Aug 9;2021:6258865. doi: 10.1155/2021/6258865. eCollection 2021.
6
sTREM-1 is a specific biomarker of TREM-1 pathway activation.可溶性髓系细胞触发受体-1(sTREM-1)是髓系细胞触发受体-1(TREM-1)通路激活的特异性生物标志物。
Cell Mol Immunol. 2021 Aug;18(8):2054-2056. doi: 10.1038/s41423-021-00733-5. Epub 2021 Jul 19.
7
Biomarkers for the Diagnosis of Neonatal Sepsis.用于新生儿败血症诊断的生物标志物。
Clin Perinatol. 2021 Jun;48(2):215-227. doi: 10.1016/j.clp.2021.03.012.
8
Effects of Neutrophil-to-Lymphocyte Ratio Combined With Interleukin-6 in Predicting 28-Day Mortality in Patients With Sepsis.中性粒细胞与淋巴细胞比值联合白细胞介素-6预测脓毒症患者 28 天病死率的效果。
Front Immunol. 2021 Mar 16;12:639735. doi: 10.3389/fimmu.2021.639735. eCollection 2021.
9
Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in neonatal sepsis.可溶性髓系细胞触发受体-1 在新生儿败血症中的作用。
J Matern Fetal Neonatal Med. 2022 Jul;35(13):2485-2492. doi: 10.1080/14767058.2020.1786520. Epub 2020 Jul 16.
10
Prognostic values of SOFA score, qSOFA score, and LODS score for patients with sepsis.序贯器官衰竭评估(SOFA)评分、快速序贯器官衰竭评估(qSOFA)评分和逻辑器官功能障碍评分(LODS)对脓毒症患者的预后价值。
Ann Palliat Med. 2020 May;9(3):1037-1044. doi: 10.21037/apm-20-984.